Daito Pharmaceutical Co.,Ltd.

4577

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-07-10FY2026

Revenue

506.5100M JPY

YoY +0.0%

Operating Income

36.4100M JPY

YoY +38.9%

Net Income

31.6100M JPY

YoY +65.7%

EPS

107.5JPY

YoY +71.3%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

506.5億円

379.9億円

253.3億円

126.6億円

Rev: 434.6億円Op: 65.5億円NI: 46.7億円

Rev: 451億円Op: 52.1億円NI: 36億円

Rev: 468.9億円Op: 38.9億円NI: 33億円

Rev: 506.4億円Op: 26.2億円NI: 19.1億円

Rev: 506.5億円Op: 36.4億円NI: 31.6億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Achievement

FY2026

Net Income126.4%

Revenue Progress506.500M

Revenue Forecast51000M

Net Income Achieved31.600M

Net Income Forecast2500M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan